| Host: |
Rabbit |
| Applications: |
WB/ELISA/IHC |
| Reactivity: |
Human/Mouse/Rat |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-Cleaved-Matrilysin-Tyr95 (94-95) is suitable for use in Western Blot, ELISA and Immunohistochemistry research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit serum by affinity-chromatography using specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-2000IHC-p 1:50-300ELISA 2000-20000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
MMP7 |
| Gene ID: |
4316 |
| Uniprot ID: |
MMP7_HUMAN |
| Immunogen Region: |
94-95 |
| Specificity: |
This antibody detects endogenous levels of Human, Mouse, Rat MMP7 (Cleaved-Tyr95, protein was cleaved amino acid sequence between 94-95 ) |
| Immunogen: |
Synthesized peptide derived from human MMP7 (Cleaved-Tyr95) |
| Function | Degrades casein, gelatins of types I, III, IV, and V, and fibronectin. Activates procollagenase. |
| Protein Name | MatrilysinMatrinMatrix Metalloproteinase-7Mmp-7Pump-1 ProteaseUterine Metalloproteinase |
| Database Links | Reactome: R-HSA-1442490Reactome: R-HSA-1474228Reactome: R-HSA-1592389Reactome: R-HSA-2022090Reactome: R-HSA-9009391 |
| Cellular Localisation | SecretedExtracellular SpaceExtracellular Matrix |
| Alternative Antibody Names | Anti-Matrilysin antibodyAnti-Matrin antibodyAnti-Matrix Metalloproteinase-7 antibodyAnti-Mmp-7 antibodyAnti-Pump-1 Protease antibodyAnti-Uterine Metalloproteinase antibodyAnti-MMP7 antibodyAnti-MPSL1 antibodyAnti-PUMP1 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
